Back to company

Tandlæge Amela Drljevic ApS: Financial statements 2023

CVR: 38491164

Tandlæge Amela Drljevic ApS (CVR 38491164) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 6,204,387 and a net result of DKK 1,861,467 compared with DKK 1,212,070 the year before. That is an increase of 12.9% compared with the year before. Equity amounted to DKK 5,464,578. The solvency ratio was 58.7%. The company had 7 employees in the financial year.

Gross Profit
6,204,387 kr.
Profit/Loss
1,861,467 kr.
Equity
5,464,578 kr.
Total Assets
9,312,025 kr.
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-6.2 mio.1.9 mio.5.5 mio.7
2022-5.5 mio.1.2 mio.3.6 mio.6
2021-5.3 mio.1.7 mio.2.4 mio.5
2020-3.7 mio.592 t.717 t.5
2019-2.8 mio.45 t.233 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

About Tandlæge Amela Drljevic ApS

Tandlæge Amela Drljevic ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2017. The company is registered under the industry Tandlægers aktiviteter. The management consists of Amela Drljevic Jørgensen. The company is owned by Michael Drljevic Jørgensen and Amela Drljevic Jørgensen. The company has 4 employees. In 2025, the company reported a gross profit of DKK 7,551,735 and a net result of DKK 2,145,840 compared with DKK 2,216,762 the year before. Equity amounted to DKK 9,705,180.

Other financial years